Author Archives: admin

Global stem cell banking market Enhancement And Its growth prospects forecast 2020 to 2027 – Scientect

By adminAugust 21, 2020Induced Pluripotent Stem Cells

Global stem cell banking market is set to witness a substantial CAGR of 11.03% in the forecast period of 2019- 2026. The report contains data of the base year 2018 and historic year 2017. The increased market growth can be identified by the increasing procedures of hematopoietic stem cell transplantation (HSCT), emerging technologies for stem cell processing, storage and preservation. Increasing birth rates, awareness of stem cell therapies and higher treatment done viva stem cell technology.

Get Sample Report + All Related Graphs & Charts (with COVID 19 Analysis) @https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-stem-cell-banking-market&pm

Competitive Analysis:

Global stem cell banking market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of inflammatory disease drug delivery market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Key Market Competitors:

Few of the major competitors currently working in global inflammatory disease drug delivery market are: NSPERITE N.V, Caladrius, ViaCord, CBR Systems, Inc, SMART CELLS PLUS, LifeCell International, Global Cord Blood Corporation, Cryo-Cell International, Inc., StemCyte India Therapeutics Pvt. Ltd, Cordvida, ViaCord, Cryoviva India, Vita34 AG, CryoHoldco, PromoCell GmbH, Celgene Corporation, BIOTIME, Inc., BrainStorm Cell Therapeutics and others

Market Definition:Global Stem Cell Banking Market

Stem cells are cells which have self-renewing abilities and segregation into numerous cell lineages. Stem cells are found in all human beings from an early stage to the end stage. The stem cell banking process includes the storage of stem cells from different sources and they are being used for research and clinical purposes. The goal of stem cell banking is that if any persons tissue is badly damaged the stem cell therapy is the cure for that. Skin transplants, brain cell transplantations are some of the treatments which are cured by stem cell technique.

Cord Stem Cell Banking MarketDevelopment and Acquisitions in 2019

In September 2019, a notable acquisition was witnessed between CBR and Natera. This merger will develop the new chances of growth in the cord stem blood banking by empowering the Nateras Evercord branch for storing and preserving cord blood. The advancement will focus upon research and development of the therapeutic outcomes, biogenetics experiment, and their commercialization among the global pharma and health sector.

Cord Stem Cell Banking MarketScope

Cord Stem Cell Banking Marketis segmented on the basis of countries into U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

All country based analysis of the cord stem cell banking marketis further analyzed based on maximum granularity into further segmentation. On the basis of storage type, the market is segmented into private banking, public banking. On the basis of product type, the market is bifurcated into cord blood, cord blood & cord tissue. On the basis of services type, the market is segmented into collection & transportation, processing, analysis, storage. On the basis of source, market is bifurcated into umbilical cord blood, bone marrow, peripheral blood stem, menstrual blood. On the basis of indication, the market is fragmented into cerebral palsy, thalassemia, leukemia, diabetes, autism.

Cord stem cell trading is nothing but the banking of the vinculum plasma cell enclosed in the placenta and umbilical muscle of an infant. This ligament plasma comprises the stem blocks which can be employed in the forthcoming time to tackle illnesses such as autoimmune diseases, leukemia, inherited metabolic disorders, and thalassemia and many others.

Market Drivers

Increasing rate of diseases such as cancers, skin diseases and others Public awareness associated to the therapeutic prospective of stem cells Growing number of hematopoietic stem cell transplantations (HSCTs) Increasing birth rate worldwide

Market Restraint

High operating cost for the therapy is one reason which hinders the market Intense competition among the stem cell companies Sometimes the changes are made from government such as legal regulations

Key Pointers Covered in the Cord Stem Cell Banking MarketIndustry Trends and Forecast to 2026

Market Size Market New Sales Volumes Market Replacement Sales Volumes Market Installed Base Market By Brands Market Procedure Volumes Market Product Price Analysis Market Healthcare Outcomes Market Cost of Care Analysis Market Regulatory Framework and Changes Market Prices and Reimbursement Analysis Market Shares in Different Regions Recent Developments for Market Competitors Market Upcoming Applications Market Innovators Study

Key Developments in the Market:

In August, 2019, Bayer bought BlueRock for USD 600 million to become the leader in stem cell therapies. Bayer is paying USD 600 million for getting full control of cell therapy developer BlueRock Therapeutics, promising new medical area to revive its drug development pipeline and evolving engineered cell therapies in the fields of immunology, cardiology and neurology, using a registered induced pluripotent stem cell (iPSC) platform. In August 2018, LifeCell acquired Fetomed Laboratories, a provider of clinical diagnostics services. The acquisition is for enhancement in mother & baby diagnostic services that strongly complements stem cell banking business. This acquisition was funded by the internal accruals which is aimed to be the Indias largest mother & baby preventive healthcare organization.

For More Insights Get FREE Detailed TOC @https://www.databridgemarketresearch.com/toc/?dbmr=global-stem-cell-banking-market&pm

Research objectives

To perceive the most influencing pivoting and hindering forces in Cord Stem Cell Banking Market and its footprint in the international market. Learn about the market policies that are being endorsed by ruling respective organizations. To gain a perceptive survey of the market and have an extensive interpretation of the Cord Stem Cell Banking Market and its materialistic landscape. To understand the structure of Cord Stem Cell Banking Market by identifying its various sub segments. Focuses on the key global Cord Stem Cell Banking Market players, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market. To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks). To project the consumption of Cord Stem Cell Banking Market submarkets, with respect to key regions (along with their respective key countries). To strategically profile the key players and comprehensively analyze their growth strategies To analyze the Cord Stem Cell Banking Market with respect to individual growth trends, future prospects, and their contribution to the total market.

Customization of the Report:

All segmentation provided above in this report is represented at country level All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)

Contact:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email @ [emailprotected]

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today! Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Read the original:
Global stem cell banking market Enhancement And Its growth prospects forecast 2020 to 2027 - Scientect

Global Tooth Regeneration Market : Industry Analysis and Forecast (2020-2027)-by Type, Application, Population Demographics and Region. – Good Night,…

By adminAugust 21, 2020Induced Pluripotent Stem Cells

Global Tooth Regeneration Marketwas valued US$ XX Mn in 2019 and is expected to reach US$ XX Mn by 2027, at a CAGR of 6.5% during a forecast period 2020-2027.

Global Tooth Regeneration Market, By Regions

Market Dynamics

The Research Report gives a comprehensive account of the drivers and restraints in the tooth regeneration. Somatic stem cells are composed and reprogrammed to induced pluripotent stem cells which can be placed in the dental lamina directly or placed in an absorbable biopolymer in the shape of the new tooth, which is a main source of the novel bioengineered teeth. Tooth replacement therapy is pondered to be a greatly attractive concept for the next generation bioengineered organ replacement.The report study has analyzed revenue impact of covid-19 pandemic on the sales revenue of market leaders, market followers and disrupters in the report and same is reflected in our analysis.

The global tooth regeneration market is mainly compelled by the high occurrence of dental problems with the new research and development activities. According to WHO, the Global Burden of Disease Study 2017 estimated that oral diseases affect close to 3.5 billion people worldwide, with caries of permanent teeth being the most common condition. Globally, it is likely that 2.3 billion people suffer from caries of permanent teeth and more than 530 million children suffer from caries of primary teeth. Additionally, positive refund policies for instance coverage of Medicaid insurance for dental loss treatment and emergence of new technologies like laser tooth generation techniques are projected to enhance the global tooth generation market throughout the estimated period.

Different researches are carried out by several academies and corporations to understand the possibility of stem cell-based regenerative medicines tooth regeneration. Though stem cell is the protuberant technology in research for tooth regeneration, several organizations are also leveraging laser, drug, and gel as mediums to regenerate teeth. For example, the Wyss Institute at Harvard University is engaged in research related to tooth regeneration using lasers. Tooth generation using stem cells is now under research through the globe. There are some key stem cells on which research are carried out such as stem cells from human exfoliated deciduous teeth (SHEDs), dental pulp stem cells, dental follicle progenitor cells (DFPCs), periodontal ligament stem cells (PDLSCs), and stem cells from apical papilla (SCAPs). A 2009 nationwide survey by the Nova South-eastern University in the U.S. publicized that around 96% of dentists expect stem cell regeneration to lead the future of the dentistry industry. However, occurrence rates are growing in low and middle-income countries. Though, some factors like the preference for endodontic treatment over tooth regeneration products in key dental surgeries and local inflammatory activity, which results in chronic complications to dental replacements, is anticipated to hamper the market throughout the forecast period.

Global Tooth Regeneration Market Segment analysis

Based on population demographics, the geriatric segment is expected to grow at a CAGR of XX% during the forecast period. According to NIH, the geriatric population has an average 18.9 remaining teeth. About 23% of the geriatric population has no teeth, making a positive market situation for manufacturing companies. The above 18 million dental procedures are anticipated to be carried out amongst the geriatric population between 2019 and 2027. Commercialization of tooth regeneration is expected to create lucrative market opportunities for industry players. Based on Type, the dentin segment accounted for a projecting share of the global tooth regeneration market in 2019, owing to the growing occurrence of dental surgery and the uprising demand for tooth regeneration in cosmetic surgery, particularly from developing economies like India, China, and Brazil.

Global Tooth Regeneration Market Regional analysis

The Asia Pacific is projected to dominate the global tooth regeneration market throughout the forecast period. Tooth regeneration addressable market is likely to be highest in the Asia Pacific, with China and India located as the major growth engines. The occurrence of tooth regeneration is projected to capture this market. Also, the number of dental procedures is anticipated to grow at the highest CAGR of ~10.8% in the Asia Pacific between 2019 and 2027. Besides, the growing incidence of dental cavities & periodontics, particularly in emerging countries like China and India has led to the rising demand for orthopedic & dental surgery. North America and Europe are estimated to collectively account for the major share of global procedures during the forecast period.

Key Developments

In June 2018, Datum Dental Ltd., the prominent provider of OSSIX brand innovative solutions for bone and tissue regeneration for dentistry, announced clearances for OSSIX Bone with Health Canada and CE Mark approval in Europe. OSSIX Bone received FDA clearance in July 2017 and was launched commercially in the USA. In April 2018, Datum Dental, the leading provider of OSSIX brand innovative solutions for bone and tissue regeneration for dentistry, announced the expansion of its global distribution network. In the USA, Dentsply Sirona Implants is now promoting the full OSSIX line.

The objective of the report is to present a comprehensive analysis of the Global Tooth Regeneration Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market has been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analysed, which will give a clear futuristic view of the industry to the decision-makers.

The report also helps in understanding Global Tooth Regeneration Market dynamics, structure by analysing the market segments and projects the Global Tooth Regeneration Market size. Clear representation of competitive analysis of key players by Application, price, financial position, Product portfolio, growth strategies, and regional presence in the Global Tooth Regeneration Market make the report investors guide. Scope of the Global Tooth Regeneration Market

Global Tooth Regeneration Market, By Type

Dentin Dental Pulp Tooth Enamel Global Tooth Regeneration Market, By Applications

Hospitals Dental Clinics Others Global Tooth Regeneration Market, By Population Demographics

Geriatric Middle-aged Adults Others Global Tooth Regeneration Market, By Regions

North America Europe Asia-Pacific South America Middle East and Africa (MEA) Key Players operating the Global Tooth Regeneration Market

Unilever Straumann Dentsply Sirona 3M Zimmer Biomet Ocata Therapeutics Integra LifeSciences Datum Dental CryoLife BioMimetic Therapeutic Cook Medical

Global Tooth Regeneration Market Request For View Sample Report Page : @https://www.maximizemarketresearch.com/request-sample/55424

About Us:

Maximize Market Research provides B2B and B2C market research on 20,000 high growth emerging technologies & opportunities in Chemical, Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.

Contact info: Name: Vikas Godage Organization: MAXIMIZE MARKET RESEARCH PVT. LTD. Email: sales@maximizemarketresearch.com Website:www.maximizemarketresearch.com

More here:
Global Tooth Regeneration Market : Industry Analysis and Forecast (2020-2027)-by Type, Application, Population Demographics and Region. - Good Night,...

Research on Cell Culture Protein Surface Coating Market (impact of COVID-19) 2020-2026: Corning, EMD Millipore, Thermo Fisher Scientific – Red &…

By adminAugust 21, 2020Induced Pluripotent Stem Cells

In this study, we have issued the much-needed information on the Global Cell Culture Protein Surface Coating Market 2020 which covers detailed information about the Cell Culture Protein Surface Coating market size, Cell Culture Protein Surface Coating market trends, industrial dynamics and Cell Culture Protein Surface Coating market share. Furthermore, it drops light on the series of instantly changing Cell Culture Protein Surface Coating market scenarios as well as upcoming assessment of numerous factors that completely impacting the global Cell Culture Protein Surface Coating market report. The research on the world Cell Culture Protein Surface Coating market illustrates the whole international market alongside a detailed analysis of the revenue growth and profitability of the Cell Culture Protein Surface Coating market.

NOTE: Our reports include the analysis of the impact of COVID-19 on this industry. Our new sample is updated which correspond in new report showing impact of Covid-19 on Industry trends. Also we are offering 20% discount

Get free sample copy of this report: https://spiremarketresearch.com/report/global-cell-culture-protein-surface-coating-market-232411#request-sample

The latest report on the worldwide Cell Culture Protein Surface Coating market represents a comprehensive understanding about the futuristic Cell Culture Protein Surface Coating market estimations, based on the historical and current predictions. It is considered to be the significant and professional document that especially focusing on the Cell Culture Protein Surface Coating market drivers, size, leading segments and topological zones. Moreover, the report splits the global Cell Culture Protein Surface Coating market size by volume and value on the basis of product types, applications, well-established vendors and major geographies.

Pivotal industry players involved in this report are:

Corning EMD Millipore Thermo Fisher Scientific Sigma-Aldrich

The Global Cell Culture Protein Surface Coating market divided by product types:

Animal-Derived Protein Human-Derived Protein Synthetic Protein Plant-Derived Protein

Cell Culture Protein Surface Coating market segregation by application:

Monoclonal Antibody Protein Therapeutics Induced Pluripotent Stem Cells Research Cryobanking Cell-Based Assays Development Others

In the recent research document, we have listed out a wide range of business policies, mergers & acquisitions, collaborations, upcoming as well as trending innovative techniques. It also demonstrates systematic information and analysis related to the Global Cell Culture Protein Surface Coating market trends, growth factors, share, segments, challenges, opportunities and forecasts details from 2020 to 2026.

The global Cell Culture Protein Surface Coating market report showcases several factors that are driving the industrial growth and meanwhile, evaluates the present market scenario, insightful details and new updates about the corresponding segments involved in the Cell Culture Protein Surface Coating market report. It also sheds light on the price trends, demand and supply ratio, historical as well as forecasted industry data, and company shares of the top Cell Culture Protein Surface Coating market players by geography.

Inquire for this report @: https://spiremarketresearch.com/report/global-cell-culture-protein-surface-coating-market-232411#inquiry-for-buying

The report has been designed with the help of series of methodologies and essential techniques like SWOT analysis, Porters Five Forces analysis, graphical representation, pie charts and real-time analytics are helpful to add more precise and clear understanding about the Cell Culture Protein Surface Coating market related facts and figures.

View post:
Research on Cell Culture Protein Surface Coating Market (impact of COVID-19) 2020-2026: Corning, EMD Millipore, Thermo Fisher Scientific - Red &...

Jocelyn McGlynn inspired people to help others – Chatham This Week

By adminAugust 19, 2020Stem Cell Clinic

Jocelyn McGlynn (left) who died Aug. 15 after a battle with acute myelomonocytic leukemia, will be greatly missed by childhood friends Anastasia Maslak (centre) and Olivia Pomajba. The trio, from Chatham, attended elementary and high school together and were roommates while attending Western University in London. Handout/Postmedia Network

While leukemia claimed the life of aspiring doctor Jocelyn McGlynn, she left a legacy that will help save others because she inspired more than 2,000 people to join Canadas stem-cell registry.

The 23-year-old Chatham woman died Aug. 15 after a lengthy battle with the disease.

Diagnosed with acute myelomoncytic leukemia on Nov. 30, 2018, the Western University student and her family took up the cause of the ongoing need for stem-cell donations, not only to help McGlynn but many others in need of the life-saving procedure.

The McGlynn family was joined by many friends and family in organizing blood donor clinics where people could also join the stem-cell registry.

Olivia Pomajba and Anastasia Maslak, two of McGlynns closest friends and her roommates at Western, were part of that effort.

That was a huge gift to be able to tangibly do something instead of just sitting at home and being very sad, said Pomajba, who helped at blood donor clinics and a swab clinic at Western University in early 2019 that attracted a record 767 people.

She said people came out of the woodwork during the months they searched for a viable stem-cell match for McGlynn.

Pomajba was amazed that many people McGlynn had met in passing were all just struck by how lovely and kind she was to them, even briefly, and wanted to help.

That was a huge blessing for me to meet all these people that shes touched who all signed up to be stem cell donors, she said.

Pomajba said McGlynn helped inspire more than 2,000 people to join the stem-cell registry. A number of the newly registered donors turned out to be stem-cell matches for other patients, she added.

McGlynns friends were amazed by the grace she showed throughout the high of finding a perfect stem-cell match and undergoing a successful transplant in February 2019 to the lows of suffering two relapses.

Her No. 1 concern was other people. I dont think she wanted us to worry about her, so she put on a really brave face and smiled the whole time, Pomajba said.

Having concern for others is something McGlynns friends knew was part of her makeup.

Maslak said McGlynn had a talent for being able to cheer people up.

I remember there were so many times, whether it be in high school or when we were living together in university, where I would be just having rough day and she would put on this performance and would have me laughing so hard I was in tears, Maslak said.

Her signature thing was, whenever we would go anywhere, she would always be holding the door open, literally, for everyone who would pass by.

She said McGlynn would smile and have conversations with people and offer her well wishes.

It would just take forever to move down the hallway in high school because she was just always so kind and friendly, Maslak said.

McGlynn is also remembered by her roommates for decorating their university home for every holiday and special occasion, including Christmas and Thanksgiving but including Halloween.

We were probably to the point we were annoying our other roommates because there were decorations from multiple holidays up all the time, Pomajba said.

Shes woven into the fabric of everything weve ever done, like every holiday, every birthday, every milestone.

McGlynn was in her final year of the four-year medical science program at Western when the leukemia first struck.

She wrote her Medical College Admission Test the previous summer and achieved a score that qualified her for acceptance at every medical school in Ontario.

She was so excited about medicine, Pomajba said. She would have had a great beside manner and been so kind to people.

McGlynn was so keen on becoming a doctor, specifically a pediatrician, that she embraced the opportunity to learn while undergoing treatment for leukemia.

During a telephone interview in early January 2019, after having already spent a month in a London hospital, McGlynn she told the Chatham Daily News: Ive learned a lot about how important wording is, how important phrasing is. I think that will definitely help me.

She added: Everyone Ive met has been awesome. Im going to use the tools theyve shown me and hopefully implement that when I reach my goal.

McGlynn is the daughter of Peter and Jacquelyn McGlynn and a sister to Maxx and Zach.

Follow this link:
Jocelyn McGlynn inspired people to help others - Chatham This Week

Animal Stem Cell Therapy Market with leading companies like ANIMAL CELL THERAPIES, Abbott Animal Hospital, VETSTEM BIOPHARMA, Veterinary Hospital and…

By adminAugust 19, 2020Stem Cell Clinic

Stem cellsare being used to treat illness and heal injuries in pets. They are injected into the body to repair muscles, joints, and ligaments that have been damaged by arthritis or injury. Some cancers are treated withstem cellstaken from the pets own bone marrow.

The report, titled Animal Stem Cell Therapy Market defines and briefs readers about its products, applications, and specifications. The research lists key companies operating in the global market and also highlights the key changing trends adopted by the companies to maintain their dominance. By using SWOT analysis and Porters five force analysis tools, the strengths, weaknesses, opportunities, and threats of key companies are all mentioned in the report. All leading players in this global market are profiled with details such as product types, business overview, sales, manufacturing base, competitors, applications, and specifications.

Sample Report with Latest Industry Trends @:

https://www.qyreports.com/request-sample/?report-id=51946

Top Key Companies Players Analyzed in this Report are:

Magellan Stem Cells, ANIMAL CELL THERAPIES, Abbott Animal Hospital, VETSTEM BIOPHARMA, Veterinary Hospital, Clinic Frisco, CO, Medivet Biologics LLC

The scope of the Animal Stem Cell Therapy Market report is as follows the report provides information on growth segments and opportunities for investment and Benchmark performance against key competitors. Geographically, the global mobile application market has been segmented into four regions such as North America, Europe, Asia Pacific and the rest of the world.

This report gives an in depth and broad understanding of Animal Stem Cell Therapy Market. With accurate data covering all key features of the prevailing market, this report offers prevailing data of leading companies. Appreciative of the market state by amenability of accurate historical data regarding each and every sector for the forecast period is mentioned. Driving forces, restraints and opportunities are given to help give an improved picture of this market investment for the forecast period.

Get Reasonable Discount on this Premium Report @:

https://www.qyreports.com/ask-for-discount/?report-id=51946

Finally, all aspects of the Global Animal Stem Cell Therapy Market are quantitatively as well qualitatively assessed to study the Global as well as regional market comparatively. This market study presents critical information and factual data about the market providing an overall statistical study of this market on the basis of market drivers, limitations and its future prospects.

Following are the List of Chapter Covers in the Animal Stem Cell Therapy Market:

Animal Stem Cell Therapy Market Overview

Global Economic Impact on Industry

Global Market Competition by Manufacturers

Global Market Analysis by Application

Marketing Strategy Analysis, Distributors/Traders

Market Effect Factors Analysis

Global Animal Stem Cell Therapy Market Forecast

For More Information:

https://www.qyreports.com/enquiry-before-buying/?report-id=51946

*If you need anything more than these then let us know and we will prepare the report according to your requirement.

About QYReports:

We at QYReports, a leading market research report publisher cater to more than 4,000 prestigious clients worldwide meeting their customized research requirements in terms of market data size and its application. Our list of customers includes renowned Chinese companys multinational companies, SMEs and private equity firms. Our business study covers a market size of over 30 industries offering you accurate, in depth and reliable market insight, industry analysis and structure. Reports specialize in forecasts needed for investing in an and execution of a new project globally and in Chinese markets.

Jones John

Contact number: +1-510-560-6005

204, Professional Center,

7950 NW 53rd Street, Miami, Florida 33166

[emailprotected]

http://www.qyreports.com

See the rest here:
Animal Stem Cell Therapy Market with leading companies like ANIMAL CELL THERAPIES, Abbott Animal Hospital, VETSTEM BIOPHARMA, Veterinary Hospital and...

Researchers Get First-Ever Look at a Rare but Vital Stem Cell in Humans – Technology Networks

By adminAugust 19, 2020Stell Cell Research

This is a false-colored, scanning electron micrograph of a neutrophil. Credit: UC San Diego School of Medicine

Read Time:

Neutrophils are the warriors of the immune system. They are always ready to spring to action to help heal injuries or fight off disease. Unless, that is, something goes wrong in their developmental process. Immature neutrophils arent all warriors they can be dangerous turncoats. High levels of immature neutrophils in the bloodstream can be a tell-tale sign of cancer and may even be a biomarker for COVID-19.

Now scientists at La Jolla Institute for Immunology (LJI) have tracked down the rare stem cells that generate neutrophils in human bone marrow. This research, published in Immunity, gives researchers a potential path for intervening in diseases where neutrophil development goes awry.

We have identified the stem cells that are the early origins of neutrophils, the most abundant blood cell type in humans, says Huy Dinh, Ph.D., a former LJI postdoctoral associate who recently moved to a faculty position at The University of WisconsinMadison. Dinh led the study with LJI Professor Catherine C. Hedrick, Ph.D. Knowing how human neutrophils develop is especially relevant today because immature neutrophils have been found to be elevated in both the blood and lungs of severe COVID-19 patients.

Despite their importance, neutrophils have proven very hard to study. They dont hold up well outside the body, and the stem cells that make them are even harder to investigate because they only live in bone marrow.

In 2018, the Hedrick Lab reported the discovery of a group of progenitor stem cells that give rise to mature neutrophils. These progenitors sole job was to generate neutrophils, yet they appeared to also promote tumor growth. The researchers believed that detecting these progenitors could give doctors a better way to catch early cancer cases. But first, the team needed to know a lot more about neutrophil development.

The new research revealed a progenitor cell type that exists even earlier in human neutrophil development. Dinh, a past SPARK Award recipient, together with Tobias Eggert, Ph.D., a LJI visiting scientist and Melissa Meyer, Ph.D., a LJI postdoc, who served as the co-first authors in the study, spearheaded the effort to use a tool called cytometry by time-of-flight (CyTOF) to distinguish these rare cells from other types of immune progenitor cells. This work also made it possible for the researchers to identify more specific protein markers on this early progenitor cell surface.

The discovery of these protein markers was important because until now, scientists have used only a few of markers to track neutrophils over time. The new study gives scientists specific markers for tracking neutrophil development from day one.

The researchers also found that cases of skin and lung cancers are often accompanied by a flood of immature neutrophils including the early progenitor cells into the bloodstream. These immature neutrophils change as they interact with tumor cells, though the researchers arent sure yet how these changes affect cancer progression.

Dinh likens the stages of neutrophil development to the cars on a train. The early progenitors are like the train engine, keeping everything going smoothly along the track to maturity. Cancer shakes everything up, and immature neutrophils jump off the track before they reach maturity. Its like the train is falling apart, Dinh says.

Neutrophil development has been in the news recently due to the COVID-19 pandemic, as studies have shown immature neutrophils are also more abundant in some patients with COVID-19. Dinh and Hedrick think perhaps the threat of the virus prompts the body to churn out neutrophils too quickly, again forcing immature cells off the track to maturity.

We need to study this phenomenon further to see if these neutrophils can be tied to case prognosis or if they can be a drug target for COVID-19, says Dinh.

The researchers hope to continue their work to discover the exact mechanisms that stop neutrophils from reaching maturity. Knowing the earliest cell that gives rise to neutrophils is really critical for trying to target and control these cells, says Hedrick. But we dont know exactly how to do that yet.

This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source.

3D Cell Cultures: Technologies and Global Markets to 2025 Featuring Agilent Technologies, BioVision, Cell Applications, Envisiontec, Mitra Biotech,…

By adminAugust 19, 2020Stell Cell Research

DUBLIN--(BUSINESS WIRE)--The "3D Cell Cultures: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering.

The report includes:

Whether the discussion is about stem cells, tissue engineering, or microphysiological systems, their vital role in drug discovery, toxicology, and other areas leading to new product development, 3D cell culture is becoming the environment that will increasingly define the basis for future advances.

To mix metaphors, 3D cell culture is also cross-roads through which just about everything else passes on its way to building knowledgebases or introducing new products. This study is needed to bring together and make sense out of the broad body of information encompassed by 3D cell culture.

Three-dimensional cell culture has been used by researchers for many years now, with early adoption and now key roles in cancer and stem cells. Organ-on-a-chip technology, also known as microphysiological systems, is leading to dramatic breakthroughs. Also, stem cell research coupled with synthetic biology is opening new areas. This study is needed to provide a perspective on these advances.

Furthermore, classical toxicology testing programs have been in place for many decades, and over the past 20 years, animal welfare and scientific activities have spurred the development of in vitro testing methods. In silico methods are advancing in novel ways that need to be analyzed and considered in terms of their impacts on cell culture.

This report investigates the recent key technical advances in 3D cell culture equipment, raw materials, assay kits, analytical methods, and clinical research organization (CRO) services. It should also be pointed out that this report takes a somewhat different position on 2D cell culture. It has been criticized for its inadequacies and the misleading information it can produce. However, a review of industry practices makes it clear that it still has its place and will contribute to future advances in unexpected ways.

The company section looks at many of the suppliers who provide equipment, assays, cells, reagents, and services used in 3D cell culture. This study sought to understand business models and market maturity dynamics in greater depth as well as providing more quantitative analysis of their operations.

Key Topics Covered

Chapter 1 Introduction

Chapter 2 Summary

Chapter 3 Highlights and Issues

Chapter 4 Tissue and Cell Culture: Technology and Product Background

Chapter 5 Assays, Imaging and Analysis

Chapter 6 Regulation and Standardization

Chapter 7 3D Models for Cancer

Chapter 8 Landscape for Toxicology and Drug Safety Testing

Chapter 9 Stem Cell Landscape

Chapter 10 Regenerative Medicine: Organ Transplants and Skin Substitutes

Chapter 11 Company Profiles

For more information about this report visit https://www.researchandmarkets.com/r/htgg5z

See the original post:
3D Cell Cultures: Technologies and Global Markets to 2025 Featuring Agilent Technologies, BioVision, Cell Applications, Envisiontec, Mitra Biotech,...

Israelis and Emiratis to develop Covid stem-cell therapy – ISRAEL21c

By adminAugust 19, 2020Stell Cell Research

Fast on the heels of the agreement between Israel and the United Arab Emirates (UAE) to establish full diplomatic relations, Haifa-based Pluristem Therapeutics signed a non-binding memorandum of understanding (MoU) with the Abu Dhabi Stem Cells Center to advance cell therapies for diseases including Covid-19.

The aim of the collaboration is to capitalize on each companys respective areas of expertise in cell therapies to deliver regenerative medicine for the benefit not only of the citizens of the UAE and Israel, but for humanity as a whole, Pluristem explained in a press release on August 17.

As ISRAEL21c reported earlier, Pluristem has treated patients with its placental PLX-PAD allogenic product via compassionate use programs in Israel and the United States and is currently conducting phase II studies in the US and EU.

Abu Dhabi Stem Cells Center has been treating Covid-19 patients with stem cells sourced from the patients blood, by returning the cells back into the patients lungs as a fine mist through a nebulizer.

The collaboration, initiated by the Better Alternatives advisory firm, would involve exchanging research results, patient samples and testing equipment.

I believe it is our obligation and privilege as business and scientific leaders to lead the way forward to strengthen collaborations, and promote innovation and education. We are honored to be on the front line of this historical moment, stated Pluristem CEO and President Yaky Yanay.

This is not the first Covid-related joint project between the two countries.

In July, Rafael Advanced Defense Systems and Israel Aerospace Industries signed agreements with Abu Dhabis Group 42 concerning R&D collaborations for solutions to SARS-CoV-2, the novel coronavirus that causes Covid-19. On August 15, UAEs APEX National Investment signed a strategic commercial agreement with Israels TeraGroup concerning SARS-CoV-2 research.

The Pluristem-Abu Dhabi Stem Cells Center MoU was signed in a video conference. But soon it may be possible to make a three-hour flight between the two Middle East countries for the first time. Prime Minister Benjamin Netanyahu said that Israel is working on establishing a direct route between Tel Aviv and Dubai and Abu Dhabi, which would fly over Saudi Arabia.

Read the original post:
Israelis and Emiratis to develop Covid stem-cell therapy - ISRAEL21c

OU professor awarded $550,178 grant by National Science Foundation – College of Arts and Sciences – 2020 – News – OU Magazine – News at OU

By adminAugust 19, 2020Stell Cell Research

Oakland University Professor Luis Villa-Diaz has been awarded a $550,178 grant by the National Science Foundation (NSF) for his research on stem cell biology and the potential use of stem cells in regenerative medicine.

Stem cells are cells with the unique ability to divide into identical daughter cells or to differentiate into specialized cell types, said Villa-Diaz, an assistant professor in the biological sciences and bioengineering departments at Oakland University. A better understanding of stem cell biology will advance knowledge of how organs and tissues are formed and maintained during the life of an organism, as stem cells are responsible for those functions.

Villa-Diaz will serve as the principle investigator on the project, which will examine the biological mechanisms that stem cells use to perform two of their main characteristics, including the capacity to divide and create an identical daughter cell a process known as self-renewal and the potential for stem cells to change their identity and become a specialized, differentiated cell.

My lab has been investigating for years these properties and new molecular pathways that are involved on both biological processes, he said. In this project, we will determine the potential function of two proteins the Focal Adhesion Kinase (FAK) and Integrin-Linked Kinase (ILK) in the nuclei of stem cells regulating the degradation of proteins involved in the regulation of genes that induce stem cell differentiation.

These roles might be unique for stem cells, as in somatic cells these proteins play other roles, Villa-Diaz added. Confirming these new activities of these proteins in the nuclei of stem cells will impact our knowledge of stem cell biology and will help us to better use these cells for therapeutic use in regenerative medicine.

In addition, this project will provide training opportunities for two new graduate students and multiple undergraduates, who will be directly involved in the research activities of this project. Dozens of graduate students will also be trained in methods to effectively communicate scientific knowledge to the public as an outreach component of the NSF grant.

This NSF award means a lot to me because it is a vote of trust on my research program, Villa-Diaz said.

Stem Cell Characterization and Analysis Tool Market 2020: Potential Growth, Challenges, and Know the Companies List Could Potentially Benefit or Loose…

By adminAugust 19, 2020Stell Cell Research

Drug Development and Discovery Embryonic Stem Cells Research

Downlaod Sample ToC to understand the CORONA Virus/COVID19 impact and be smart in redefining business strategies. https://inforgrowth.com/CovidImpact-Request/6488438/stem-cell-characterization-and-analysis-tool-marke

Be the first to knock the door showing the potential that Stem Cell Characterization and Analysis Toolmarket is holding in it. Uncover the Gaps and Opportunities to derive the most relevant insights from our research document to gain market size.

A major chunk of this Global Stem Cell Characterization and Analysis ToolMarket research report is talking about some significant approaches for enhancing the performance of the companies. Marketing strategies and different channels have been listed here. Collectively, it gives more focus on changing rules, regulations, and policies of governments. It will help to both established and new startups of the market.

The study objectives of this report are:To analyze global Stem Cell Characterization and Analysis Toolstatus, future forecast, growth opportunity, key market, and key players. To present the Stem Cell Characterization and Analysis Tooldevelopment in the United States, Europe, and China. To strategically profile the key players and comprehensively analyze their development plan and strategies. To define, describe and forecast the market by product type, market, and key regions.

Get Chance of 20% Extra Discount, If your Company is Listed in Above Key Players List https://inforgrowth.com/discount/6488438/stem-cell-characterization-and-analysis-tool-marke

Major Points from Table of Contents

1 Stem Cell Characterization and Analysis Tool Stem Cell Characterization and Analysis Tool Market Overview 2 Stem Cell Characterization and Analysis Tool Market Competition by Manufacturers 3 Production Capacity by Region 4 Global Stem Cell Characterization and Analysis Tool Market by Regions 5 Production, Revenue, Price Trend by Type 6 Global Stem Cell Characterization and Analysis Tool Market Analysis by Application 7 Company Profiles and Key Figures in Stem Cell Characterization and Analysis Tool Business 8 Stem Cell Characterization and Analysis Tool Manufacturing Cost Analysis 9 Marketing Channel, Distributors and Customers 10 Market Dynamics 11 Production and Supply Forecast 12 Consumption and Demand Forecast 13 Forecast by Type and by Application (2021-2026) 14 Research Finding and Conclusion 15 Methodology and Data Source.

Get Chance of 20% Extra Discount, If your Company is Listed in Above Key Players List https://inforgrowth.com/discount/6488438/stem-cell-characterization-and-analysis-tool-marke

FOR ALL YOUR RESEARCH NEEDS, REACH OUT TO US AT: Address: 6400 Village Pkwy suite # 104, Dublin, CA 94568, USA Contact Name: Rohan S. Email:[emailprotected] Phone: +1-909-329-2808 UK: +44 (203) 743 1898 Website: http://www.inforgrowth.com

Read this article:
Stem Cell Characterization and Analysis Tool Market 2020: Potential Growth, Challenges, and Know the Companies List Could Potentially Benefit or Loose...